| Authors: |
Carmona J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Chavarria E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Donoghue K; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., von Gertten C; Karolinska Institutet, Stockholm, Sweden., Oberrauch P; German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Pailler E; Gustave Roussy, Villejuif, France., Scoazec G; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Weijer R; Netherlands Cancer Institute, Amsterdam, the Netherlands., Balmaña J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Brana I; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Brunelli C; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Delaloge S; Interception Programme, Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Deloger M; Gustave Roussy, Villejuif, France., Delpy P; Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany., Ernberg I; Department of Microbiology, Tumor and Cell Biology (MTC), Cancer Center Karolinska (CCK) & Biomedicum. Karolinska Institutet, Stockholm, Sweden., Fitzgerald RC; Department of Oncology, Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom., Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Lablans M; Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Complex Medical Informatics, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany., Lëhtio J; Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.; Karolinska University Hospital, Stockholm, Sweden., Lopez C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Fernández M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Miceli R; Unit of Biostatistics for Clinical Research, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Perez-Lopez R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Provenzano E; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Schmidt MK; Division of Molecular Pathology, NKI Center for Early Diagnostics, Lead Early Detection Research Theme, Netherlands Cancer Institute, Amsterdam, the Netherlands., Serrano C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Tamborero D; Department of Oncology and Pathology, Karolinska Institutet, SciLifeLab, Solna, Sweden.; Karolinska University Hospital, Stockholm, Sweden., Wirta V; Department of Microbiology, Tumor and Cell Biology, Karolinska Instiutet, Stockholm, Sweden.; Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden., Baird RD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Barker K; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Barlesi F; Gustave Roussy, Villejuif, France.; Paris Saclay University, Villejuif, France., Baumann M; German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Bergh J; Karolinska Institutet, Stockholm, Sweden.; Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Solna, Sweden., de Braud F; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Fizazi K; Gustave Roussy, Villejuif, France., Fröhling S; German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Piris-Giménez A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Seamon K; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Van der Heijden MS; Netherlands Cancer Institute, Amsterdam, the Netherlands., Zwart W; Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands., Tabernero J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. |
